Skip to main content
. 2022 Sep 20;23(19):10989. doi: 10.3390/ijms231910989

Figure 9.

Figure 9

Hypothetical working model how Empagliflozin might improve skeletal muscle function in settings of HFpEF by the modulation of mitochondrial oxidative phosphorylation, myosteatosis and telethonin expression. UPS = ubiquitin proteasome system.↑, ↓ = up- or downregulated by Empa, ? and dottet line = exact pathway not defined yet.